José Suárez de Lezo

TL;DR: A network meta-analysis with a mixed-treatment comparison method to combine direct within-trial comparisons between stents with indirect evidence from other trials while maintaining randomisation found sirolimus-eluting stents seem to be clinically better than bare-metal and paclitaxel-eluted stents.

TL;DR: This work considers that this new approach, compared to previous classifications, makes the description of the anatomy of coronary bifurcations much more simple, a factor which is technically and strategically significant when facing percutaneous treatment and assessing its results.

TL;DR: This nuevo enfoque facilita the descripcion of the anatomia of las bifurcaciones, lo que tiene implicaciones tecnicas y estrategicas a la hora of afrontar el tratamiento percutaneo y valorar su resultado.

TL;DR: Sirolimus-eluting stents are superior to PES in terms of a significant reduction of the risk of reintervention and stent thrombosis, especially after the first year from the procedure.

TL;DR: Both strategies are effective in reducing the restenosis rate, with no differences in terms of clinical outcome, and elective SB stenting seems to provide no advantages over the simpler stent jail followed by SB balloon dilation.